Scarica l'app Stockscreener
1.30
1.52%
-0.02
Dopo l'orario di chiusura:
1.20
-0.10
-7.69%
Precedente Chiudi:
$1.32
Aprire:
$1.3
Volume 24 ore:
24,644
Relative Volume:
0.02
Capitalizzazione di mercato:
$4.95M
Reddito:
$556.00K
Utile/perdita netta:
$-5.28M
Rapporto P/E:
-0.6075
EPS:
-2.14
Flusso di cassa netto:
$-6.23M
1 W Prestazione:
-3.70%
1M Prestazione:
-15.58%
6M Prestazione:
-48.92%
1 anno Prestazione:
-51.67%
Intervallo 1D:
$1.26
$1.34
Intervallo di 1 settimana:
$1.26
$1.37
Portata 52W:
$1.0266
$3.79
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Nome
Cyclerion Therapeutics Inc
Settore
Industria
Telefono
617-621-7722
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Compare CYCN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
1.30 | 5.02M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.05 | 123.82B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.28 | 81.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
816.95 | 52.00B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.36 | 44.14B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
352.23 | 40.83B | 4.98B | 69.60M | 525.67M | 0.5198 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-20 | Iniziato | Truist | Buy |
| 2021-09-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Iniziato | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie
CYCN: Positive Feedback from FDA Sets Stage for Phase 2 Trial of CYC-126 in 2H26 - Research Tree
Tech Rally: Is Cyclerion Therapeutics Inc stock a good pick for beginnersJuly 2025 Final Week & Community Consensus Trade Signals - baoquankhu1.vn
Is Cyclerion Therapeutics Inc. stock a good pick for beginnersJuly 2025 Update & High Conviction Buy Zone Alerts - mfd.ru
Mobix Labs and Peraso Engage in Talks for Possible Acquisition - Intellectia AI
Volatility Watch: Can Cyclerion Therapeutics Inc deliver alphaWall Street Watch & Entry Point Confirmation Alerts - baoquankhu1.vn
Cyclerion receives FDA feedback on depression treatment development - Investing.com Nigeria
Cyclerion To Advance CYC-126 Into Phase 2 Study For Treatment-resistant Depression - Nasdaq
Cyclerion Gains FDA Support for CYC-126 Depression Study - TipRanks
Cyclerion Therapeutics announces progress toward Cyc-126 phase 2 proof-of-concept study with FDA feedback - marketscreener.com
Anesthesia-based therapy for treatment-resistant depression enters Phase 2 - Stock Titan
Is Cyclerion Therapeutics Inc. a cyclical or defensive stockPrice Action & Scalable Portfolio Growth Ideas - mfd.ru
Can Cyclerion Therapeutics Inc. deliver alphaWeekly Earnings Recap & Capital Efficiency Focused Strategies - mfd.ru
Aug PreEarnings: What is the target price for Cyclerion Therapeutics Inc stockAnalyst Upgrade & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Brokers Offer Predictions for CYCN FY2025 Earnings - Defense World
Profit Recap: What is Cyclerion Therapeutics Incs market position2025 Market Outlook & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Investor Mood: Why is Hello Group Inc Depositary Receipt stock going downJuly 2025 Weekly Recap & Target Return Focused Picks - baoquankhu1.vn
Top Penny Stocks To Follow NowJanuary 6th - MarketBeat
Weekly Earnings: Is Cyclerion Therapeutics Inc attractive for institutional investorsWatch List & Consistent Return Investment Signals - baoquankhu1.vn
Is Cyclerion Therapeutics Inc. stock a safe buy before earningsJuly 2025 Momentum & AI Based Buy and Sell Signals - Улправда
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Why Cyclerion Therapeutics Inc. stock could rally in 2025Rate Hike & Real-Time Buy Zone Alerts - Улправда
Why retail investors favor Cyclerion Therapeutics Inc. stockTreasury Yields & Daily Entry Point Trade Alerts - Улправда
Top Penny Stocks To Follow Now – January 6th - Defense World
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Will Cyclerion Therapeutics Inc. stock benefit from upcoming earnings reports2026 world cup usa national team round of 32 playmakers high defensive line expert forecast expert opinion - ulpravda.ru
Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant DepressionSlideshow (NASDAQ:CYCN) 2026-01-07 - Seeking Alpha
Exciting Surge in Cyclerion: What’s Next? - StocksToTrade
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Cyclerion Therapeutics Collaboration Sparks Curiosity - timothysykes.com
Cyclerion, Medsteer form strategic anesthetic technology alliance - TipRanks
Cyclerion Therapeutics stock jumps in premarket after Medsteer deal — what CYCN investors watch next - TechStock²
Stay updated with the stocks that are on the move in today's pre-market session. - Chartmill
Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression - Sahm
Morning Market Movers: CYCN, AZI, AEVA, OS See Big Swings - RTTNews
Cyclerion (CYCN) Enters Exclusive Collaboration with Medsteer to Advance CYC-126 Clinical Trials - Intellectia AI
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Cyclerion partners with Medsteer to advance depression treatment platform By Investing.com - Investing.com Nigeria
Cyclerion Expands Partnership With Medsteer; Plans Phase 2 Trial Of CYC-126 In 2H 2026; Stock Up - Nasdaq
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Benzinga
Critical Review: Cyclerion Therapeutics (NASDAQ:CYCN) & BeyondSpring (NASDAQ:BYSI) - Defense World
Cyclerion Therapeutics Inc. (CYCN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cyclerion announces strategic agreement with Medsteer - marketscreener.com
Cyclerion Therapeutics (CYCN) Enhances Depression Treatment Prog - GuruFocus
Wondering what's happening in today's after-hours session? - Chartmill
Cyclerion partners with Medsteer to advance depression treatment platform - Investing.com India
Cyclerion Therapeutics stock soars after strategic Medsteer collaboration By Investing.com - Investing.com Nigeria
Cyclerion Therapeutics Inc Azioni (CYCN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.52%
1.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):